Financhill
Back

Keros Therapeutics Stock Predictions

Keros Therapeutics Stock Forecast

  • Over the next 52 weeks, Keros Therapeutics has on average historically fallen by 2.7% based on the past 3 years of stock performance.
  • Keros Therapeutics has fallen lower in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
  • Is Keros Therapeutics Stock Undervalued?
    The current Keros Therapeutics [KROS] share price is $66.08. The Score for KROS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • KROS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Keros Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Keros Therapeutics has on average historically fallen by 2.7% based on the past 3 years of stock performance.

Keros Therapeutics Stock Rating

Buy
62
Keros Therapeutics (KROS) is a Buy

Is Keros Therapeutics overpriced?

  • Keros Therapeutics has fallen lower in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%

Keros Therapeutics Stock Price History

Is KROS stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing slight buying pressure.

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
kerostx.com

52-Week Data

52-Week High:
66.98
52-Week Low:
27.02

Prediction Charts

Market Cap:
1.98B
Price in USD:
66.08
Volume:
401.53K
Beta:
1.13

Technical Analysis

SMA50:
50.15
SMA100:
40.18
SMA200:
40.07
52-Wk Change:
24.21%

Stock Predictions

  • Is Keros Therapeutics stock public?
    Yes, Keros Therapeutics is a publicly traded company.
  • What is the Keros Therapeutics stock quote today?
    The Keros Therapeutics stock price is 66.08 USD today.
  • How to buy Keros Therapeutics stock online?
    You can buy Keros Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-6 53.70 52.21 54.49 51.57
Feb-7 52.10 51.41 53.00 50.90
Feb-8 51.54 51.26 57.24 50.10
Feb-9 51.63 53.49 54.31 51.63
Feb-12 53.50 57.35 57.39 53.50
Feb-13 55.55 56.21 57.17 54.21
Feb-14 57.00 59.10 59.34 55.47
Feb-15 59.46 58.77 60.94 58.27
Feb-16 58.73 59.49 61.09 56.22
Feb-20 59.19 60.77 61.31 59.19
Feb-21 61.38 59.71 62.37 59.42
Feb-22 59.56 60.88 62.61 59.13
Feb-23 60.95 63.61 64.73 60.10
Feb-26 63.41 66.08 66.98 63.41

Keros Therapeutics Earnings

Keros Therapeutics Earnings Report: Per Share Keros Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Keros Therapeutics Forecast Revenue Growth

Keros Therapeutics Stock Analysis: Historical quarterly revenues per share for Keros Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and a decrease next year of $0.49 per share.

* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.